Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Middle-East and Africa Cancer Vaccines Market - Growth, Trends, and Forecasts (2020 - 2025)

Published by Mordor Intelligence Pvt Ltd Product code 964879
Published Content info 90 Pages
Delivery time: 2-3 business days
Price
Back to Top
Middle-East and Africa Cancer Vaccines Market - Growth, Trends, and Forecasts (2020 - 2025)
Published: August 1, 2020 Content info: 90 Pages
Description

The incidence of cancer is increasing every year, which has primarily increased the demand for vaccines in research and development for cancers. The cancer is found damaging the immune system, as cancer cells produce self-antigen. The cancer vaccines thus play a vital role in the maintenance of the immune system, as they are considered to be biological response modifiers.

These cancer vaccines target the infectious agents that may cause cancer, through the production of the antibodies. Cancer vaccines are thus considered to be a new therapy and are not popular, as compared to the other alternative therapeutic drugs. However, cancer vaccines have shown great potential in both preventive and therapeutic ways.

Moreover, healthcare physicians are looking for alternate therapies, due to the huge burden of cancer cases and the side effects of the present therapies. Hence, the market for cancer vaccines is expected to grow at a high rate, during the forecast period.

Key Market Trends

Cervical Cancer Segment is Expected to grow Fastest During the Forecast Period

The increasing prevalence of cervical cancer in the region is considered to be the major driving factor for the market growth. According to Globocan 2018, 11.3 % of cancers are cervical cancer, i. e 119,284 cases have been registered for the year 2018 in Africa. With this huge patient pool and a huge scope of the market, many major players are also looking into investing in the region.

Furthermore, high-quality, sustainable projects, such as in Eldoret (AMPATH Oncology) the work of Hospice Africa Uganda, the collaborations between Crumlin Children's Hospital (Dublin, Ireland) and the Muhimbili University of Health and Allied Sciences (Dar-es-Salaam) Tanzania, etc. contributes in a positive manner towards cancer control thereby boosting the cancer vaccine market.

Competitive Landscape

The Middle East and Africa Cancer Vaccines Market are moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments. Some of the major players are Astellas Pharma Inc., AstraZeneca PLC, Merck & Co. Inc, GlaxoSmithKline, Bristol-Myers Squibb.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Table of Contents
Product Code: 51289

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Number of Cancer Cases
    • 4.2.2 Technological Developments in Cancer Vaccines
  • 4.3 Market Restraints
    • 4.3.1 Presence of Alternative Therapies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Recombinant Cancer Vaccines
    • 5.1.2 Whole-cell Cancer Vaccines
    • 5.1.3 Viral Vector and DNA Cancer Vaccines
    • 5.1.4 Other Technologies
  • 5.2 By Treatment Method
    • 5.2.1 Preventive Vaccine
    • 5.2.2 Therapeutic Vaccine
  • 5.3 By Application
    • 5.3.1 Prostate Cancer
    • 5.3.2 Cervical Cancer
    • 5.3.3 Other Applications (Liver, Skin, etc.)
  • 5.4 Geography
    • 5.4.1 Middle-East & Africa
      • 5.4.1.1 GCC
      • 5.4.1.2 South Africa
      • 5.4.1.3 Rest of Middle-East & Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Astellas Pharma Inc.
    • 6.1.2 AstraZeneca PLC
    • 6.1.3 Merck & Co. Inc.
    • 6.1.4 GlaxoSmithKline PLC
    • 6.1.5 Bristol-Myers Squibb
    • 6.1.6 Dendreon
    • 6.1.7 Sanofi SA

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top